GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACST
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Acasti Pharma stock upgraded to Hold/Accumulate.
(Updated on Apr 18, 2024)

Hold candidate since Apr 18, 2024 PDF

The Acasti Pharma stock price fell by -3.76% on the last day (Thursday, 18th Apr 2024) from $3.19 to $3.07. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 3.59% from a day low at $3.06 to a day high of $3.17. The price has been going up and down for this period, and there has been a -9.71% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -7 thousand shares and in total, 9 thousand shares were bought and sold for approximately $28.45 thousand.

Given the current short-term trend, the stock is expected to rise 46.68% during the next 3 months and, with a 90% probability hold a price between $4.50 and $5.42 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACST Signals & Forecast

There are few to no technical positive signals at the moment. The Acasti Pharma stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.31 and $3.38. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -11.01%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Acasti Pharma stock

Acasti Pharma finds support from accumulated volume at $3.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.110 between high and low, or 3.59%. For the last week the stock has had daily average volatility of 3.42%

Acasti Pharma is oversold on RSI14 (11). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: $2.88 (-6.32%) (This stock has low daily movements and this gives low risk. Low RSI14 is 11 which reduces the risk some. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (ACST) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Acasti Pharma to open at $3.10, and during the day (based on 14 day Average True Range), to move between $2.96 and $3.18, which gives a possible trading interval of +/-$0.113 (+/-3.68%) up or down from last closing price. If Acasti Pharma takes out the full calculated possible swing range there will be an estimated 7.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.06 (0.33%) than the resistance at $3.34 (8.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Acasti Pharma stock A Buy?

Acasti Pharma holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.611 Hold/Accumulate Upgraded

Predicted Opening Price for Acasti Pharma of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$3.10 ( 0.98%) $3.07

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACST

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.21 4.56 %
R2 3.17 3.19 %
R1 3.14 2.35 %
Current price: 3.07
Support S1 3.06 -0.392 %
S2 3.03 -1.24 %
S3 2.99 -2.61 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.43 11.73 %
R2 3.40 10.75 %
R1 3.34 8.79 %
Current price 3.07
Support S1 3.06 -0.326%
S2 2.61 -14.98%
S3 2.42 -21.17%

FAQ

What is the symbol for Acasti Pharma Stock and on which exchange is it traded?
The symbol for Acasti Pharma is ACST and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Acasti Pharma Stock?
Acasti Pharma holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Acasti Pharma Stock?
Acasti Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Acasti Pharma Stock.

What's the current price of Acasti Pharma Stock?
As of the end of day on the 2024-04-18, the price of an Acasti Pharma (ACST) share was $3.07.

What is the 52-week high and low for Acasti Pharma Stock?
The 52-week high for Acasti Pharma Stock is $3.76 and the 52-week low is $0.430.

What is the market capitalization of Acasti Pharma Stock?
As of the 2024-04-18, the market capitalization of Acasti Pharma is 29.983M.

When is the next earnings date for Acasti Pharma?
The upcoming earnings date for Acasti Pharma is Jun 28, 2024.
Click to get the best stock tips daily for free!

About Acasti Pharma

Acasti Pharma Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.... ACST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT